Cargando…

Somatostatin receptor expression in parathyroid neoplasms

INTRODUCTION: Parathyroid carcinoma represents a rare cause of primary hyperparathyroidism. Distinguishing carcinoma from the benign tumors underlying primary hyperparathyroidism remains challenging. The diagnostic criteria for parathyroid carcinoma are local and/or metastatic spreading. Atypical pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Storvall, Sara, Leijon, Helena, Ryhänen, Eeva, Louhimo, Johanna, Haglund, Caj, Schalin-Jäntti, Camilla, Arola, Johanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709562/ https://www.ncbi.nlm.nih.gov/pubmed/31336364 http://dx.doi.org/10.1530/EC-19-0260

Ejemplares similares

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms
por: Storvall, Sara, et al.
Publicado: (2023)

MGMT Promoter Methylation and Parathyroid Carcinoma
por: Storvall, Sara, et al.
Publicado: (2019)

CDC73 Intragenic Deletion in Familial Primary Hyperparathyroidism Associated With Parathyroid Carcinoma
por: Korpi-Hyövälti, Eeva, et al.
Publicado: (2014)

Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide
por: Storvall, Sara, et al.
Publicado: (2018)

PCSK2 expression in neuroendocrine tumors points to a midgut, pulmonary, or pheochromocytoma–paraganglioma origin
por: Remes, Satu Maria, et al.
Publicado: (2020)

Correlation of Somatostatin Receptor 1–5 Expression, [(68)Ga]Ga-DOTANOC, [(18)F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms
por: Majala, Susanna, et al.
Publicado: (2021)

Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report
por: Ryhänen, Eeva M., et al.
Publicado: (2021)

Adrenocortical carcinoma: presentation and outcome of a contemporary patient series
por: Kostiainen, Iiro, et al.
Publicado: (2019)

Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument
por: Ryhänen, Eeva M, et al.
Publicado: (2015)

Concomitant Tumor Expression of EGFR and TATI/SPINK1 Associates with Better Prognosis in Colorectal Cancer
por: Koskensalo, Selja, et al.
Publicado: (2013)

Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms
por: Becker, Anna, et al.
Publicado: (2021)

Lack of MMP-9 expression is a marker for poor prognosis in Dukes’ B colorectal cancer
por: Koskensalo, Selja, et al.
Publicado: (2012)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling
por: Viukari, Marianna, et al.
Publicado: (2022)

Cushing's syndrome, pheochromocytoma, or both?
por: Kullamaa, Liisa, et al.
Publicado: (2023)

ENDOCRINOLOGY IN THE TIME OF COVID-19: Clinical management of neuroendocrine neoplasms (NENs)
por: Casey, Ruth T, et al.
Publicado: (2020)

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
por: del Olmo-Garcia, Maria Isabel, et al.
Publicado: (2021)

A deep learning–based algorithm for tall cell detection in papillary thyroid carcinoma
por: Stenman, Sebastian, et al.
Publicado: (2022)

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread
por: Vesterinen, Tiina, et al.
Publicado: (2019)

IDH1 Expression via the R132H Mutation–Specific Antibody in Adrenocortical Neoplasias—Prognostic Impact in Carcinomas
por: Pennanen, Mirkka, et al.
Publicado: (2020)

Mediastinal Cystic Parathyroid Adenoma Diagnosed by Somatostatin Receptor Scintigraphy
por: Yokota, Kenichi, et al.
Publicado: (2020)

Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
por: Majala, Susanna, et al.
Publicado: (2019)

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
por: Yliaska, Iina, et al.
Publicado: (2022)

Association of periodontitis and complications after pancreatic surgery
por: Hermunen, Kethe M, et al.
Publicado: (2023)

Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)
por: Bollerslev, Jens, et al.
Publicado: (2019)

Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
por: Vesterinen, Tiina, et al.
Publicado: (2021)

Somatostatin receptor scintigraphy in the follow up of neuroendocrine neoplasms of appendix
por: Saponjski, Jelena, et al.
Publicado: (2020)

Clinical usefulness of Somatostatin Receptor Scintigraphy in the Diagnosis of Neuroendocrine Neoplasms
por: Inaba, Yoshitaka, et al.
Publicado: (2022)

Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas
por: Vesterinen, Tiina, et al.
Publicado: (2023)

European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021)
por: Bollerslev, Jens, et al.
Publicado: (2021)

Screening for germline KCNQ1 and KCNE2 mutations in a set of somatotropinoma patients
por: Iivonen, Anna-Pauliina, et al.
Publicado: (2018)

Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review
por: Priyadarshini, Shista, et al.
Publicado: (2022)

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
por: Mai, Rebekka, et al.
Publicado: (2019)

Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
por: Kaemmerer, Daniel, et al.
Publicado: (2015)

Long-term morbidity and mortality in patients diagnosed with an insulinoma
por: Peltola, Elina, et al.
Publicado: (2021)

Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms
por: Cantone, Maria Celeste, et al.
Publicado: (2021)

A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion
por: Schalin-Jäntti, Camilla, et al.
Publicado: (2015)

High TKTL1 expression as a sign of poor prognosis in colorectal cancer with synchronous rather than metachronous liver metastases
por: Peltonen, Reetta, et al.
Publicado: (2020)

Incidentally Detected Thyroid Follicular Neoplasm on Somatostatin Receptor Imaging and Post-therapy Scan
por: Sood, Apurva, et al.
Publicado: (2017)

Primary hepatic neuroendocrine neoplasm diagnosed by somatostatin receptor scintigraphy: A case report
por: Akabane, Miho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qkid9onjvs2iv2ue6eo1ctg3nl